Abstract
Ushbu maqolada klimakterik davrdagi ayollarda urogenital tizim salomatligini baholashda mikroRNA (miRNA) profillari asosida tashxis va monitoring usullarining ahamiyati tahlil qilindi. Tadqiqotda postmenopauza va perimenopauza davridagi ayollar guruhi o‘rganilib, miRNA ekspressiyasi urogenital atrofiyaning dastlabki belgilarini aniqlashda yuqori sezgirlikka ega ekani ko‘rsatildi. Maqola natijalari klinik amaliyotda individual profilaktika va davolash strategiyalarini ishlab chiqish uchun muhim asos bo‘lib xizmat qiladi.
References
Ali, S., & Farooq, U. (2023). Role of microRNAs in genitourinary syndrome of menopause. Journal of Women's Health Research, 12(3), 145–152.
2. Petrova, A. N., & Smirnova, E. V. (2022). MicroRNA expression patterns during climacteric period. Gynecology and Endocrinology, 28(5), 78–84.
3. Wang, L., et al. (2021). miRNA biomarkers for urogenital health in postmenopausal women. BMC Genomics, 22(1), 564.
4. Karimova, D. (2020). Urogenital sindrom epidemiologiyasi va diagnostikasi. Tibbiyot va Hayot, 4(2), 33–38.
5. Smith, R., & Lee, C. (2019). MicroRNA-based diagnostics: Opportunities and challenges. Molecular Medicine Reports, 20(6), 5123–5131.
6. Qodirova, S. (2023). Klimakterik davrda estrogen yetishmovchiligi va urogenital sindrom. O‘zbekiston Tibbiyot Jurnali, 1(3), 41–46.
7. Johnson, P. (2022). Personalized medicine and microRNAs in women’s health. Clinical Chemistry, 68(9), 1156–1164.